Literature DB >> 10599400

[Detection of Helicobacter pylori by polymerase reaction in bile samples from gallbladder and bile stones].

J Monti1, M Fay, C Banchio, R Améndola, R Farías, A Musi, A Sánchez, L Kesner, J Katz, F Ferro, Z Kogan, R Corti.   

Abstract

Some papers report helicobacter pylori existence in bile from surgical specimens obtained during gallbladder or bile ducts surgery. The aim of this work was search by PCR, H. Pylori presence in bile specimens from patients suffering of gallbladder stones or by bile ducts stones. Bile samples were obtained by gallbladder punction during cholecystectomy in 26 patients, 19 of them with gallbladder stones and 7 also with gallbladder stones and bile duct stones. Age ranged from 22-69 years old, median 49.6 years old. Samples were sent to specialized biomolecular laboratory to perform PCR techniques. Two of 26 patients (7.6%) had positive reaction for the presence of DNA of H. Pylori in bile samples. Our research suggest that DNA of H. Pylori can be founded in bile samples patients with gallbladders and duct stones in Argentina.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599400

Source DB:  PubMed          Journal:  Acta Gastroenterol Latinoam        ISSN: 0300-9033


  3 in total

1.  Identification of Helicobacter pylori in Gallstone, Bile, and Other Hepatobiliary Tissues of Patients with Cholecystitis.

Authors:  Jin-Woo Lee; Don Haeng Lee; Jung Il Lee; Seok Jeong; Kye Sook Kwon; Hyung Gil Kim; Yong Woon Shin; Young Soo Kim; Mi Sook Choi; Si Young Song
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

2.  Association of Helicobacter pylori with hepatobiliary stone disease, a prospective case control study.

Authors:  Mohammad Yousuf Dar; Sadaf Ali; Abdul Hameed Raina; Manzoor A Raina; O J Shah; Mubashir A Shah; Syed Mudassar
Journal:  Indian J Gastroenterol       Date:  2016-09-16

3.  Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract.

Authors:  C de Martel; M Plummer; J Parsonnet; L-J van Doorn; S Franceschi
Journal:  Br J Cancer       Date:  2008-11-25       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.